NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLC Sponsored ADRDR | 251.75 B USD | 81.70 USD | −0.10% | 2.46 M | 0.69 | 30.65 | 2.67 USD | +29.16% | 1.88% | Health technology | Strong buy |
 AMGNAmgen Inc. | 152.7 B USD | 283.64 USD | +1.26% | 2.3 M | 1.23 | 23.21 | 12.22 USD | +110.59% | 3.31% | Health technology | Buy |
 GILDGilead Sciences, Inc. | 142.75 B USD | 115.05 USD | +2.02% | 6.95 M | 1.46 | 22.89 | 5.03 USD | +514.42% | 2.71% | Health technology | Buy |
 SNYSanofi SA Sponsored ADRDR | 112.9 B USD | 46.50 USD | +2.58% | 7.26 M | 2.81 | 11.61 | 4.01 USD | +120.81% | 3.44% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 101.56 B USD | 396.12 USD | −0.20% | 1.17 M | 0.77 | 28.31 | 13.99 USD | — | 0.00% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 60.77 B USD | 573.38 USD | +1.09% | 960.39 K | 0.96 | 14.45 | 39.69 USD | +5.10% | 0.46% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 59.25 B USD | 452.00 USD | −0.34% | 751.5 K | 0.78 | — | −2.47 USD | −310.00% | 0.00% | Health technology | Buy |
 ARGXargenx SE Sponsored ADRDR | 45.61 B USD | 750.78 USD | +2.33% | 486 K | 1.24 | 38.17 | 19.67 USD | — | 0.00% | Health technology | Strong buy |
 ONCBeOne Medicines Ltd. Sponsored ADRDR | 42.03 B USD | 341.80 USD | +7.24% | 357.69 K | 1.20 | — | −1.72 USD | +66.16% | 0.00% | Health technology | Strong buy |
 INSMInsmed Incorporated | 30.67 B USD | 145.10 USD | +1.80% | 2.53 M | 1.05 | — | −5.70 USD | −5.65% | 0.00% | Health technology | Strong buy |
 BNTXBioNTech SE Sponsored ADRDR | 27.04 B USD | 112.46 USD | +8.66% | 2.05 M | 2.47 | — | −1.60 USD | +30.82% | 0.00% | Health technology | Buy |
 RPRXRoyalty Pharma plc | 21.04 B USD | 36.07 USD | −2.25% | 9.23 M | 2.74 | 15.70 | 2.30 USD | +52.85% | 2.41% | Health technology | Buy |
 BIIBBiogen Inc. | 20.62 B USD | 140.67 USD | +0.52% | 1.56 M | 1.04 | 13.46 | 10.45 USD | +31.65% | 0.00% | Health technology | Buy |
 SMMTSummit Therapeutics Inc. | 19.3 B USD | 25.98 USD | +9.16% | 3.41 M | 1.12 | — | −1.01 USD | −338.19% | 0.00% | Health technology | Strong buy |
 UTHRUnited Therapeutics Corporation | 18.11 B USD | 400.52 USD | +5.27% | 924.69 K | 0.84 | 15.64 | 25.61 USD | +17.66% | 0.00% | Health technology | Buy |
 INCYIncyte Corporation | 16.92 B USD | 86.64 USD | +1.40% | 1.39 M | 0.83 | 19.70 | 4.40 USD | +1,139.45% | 0.00% | Health technology | Buy |
 GMABGenmab A/S Sponsored ADRDR | 16.76 B USD | 27.54 USD | +0.58% | 2.26 M | 1.42 | 13.75 | 2.00 USD | +64.43% | 0.00% | Health technology | Buy |
 ILMNIllumina, Inc. | 15.21 B USD | 98.93 USD | +1.28% | 1.52 M | 1.12 | 12.53 | 7.90 USD | — | 0.00% | Health technology | Buy |
 NBIXNeurocrine Biosciences, Inc. | 14.29 B USD | 144.10 USD | +2.64% | 1.23 M | 1.64 | 42.53 | 3.39 USD | +2.34% | 0.00% | Health technology | Strong buy |
 TEMTempus AI, Inc. | 13.83 B USD | 79.62 USD | +1.92% | 9 M | 0.96 | — | −1.18 USD | +76.46% | 0.00% | Technology services | Buy |
 MEDPMedpace Holdings, Inc. | 13.68 B USD | 486.98 USD | +0.96% | 233.79 K | 0.75 | 36.22 | 13.45 USD | +26.42% | 0.00% | Commercial services | Neutral |
 ASNDAscendis Pharma A/S Sponsored ADRDR | 12.47 B USD | 205.91 USD | +3.93% | 461.01 K | 1.10 | — | −4.97 USD | +46.81% | 0.00% | Health technology | Strong buy |
 VTRSViatris Inc. | 12.24 B USD | 10.50 USD | +1.65% | 7.29 M | 1.00 | — | −2.91 USD | −435.49% | 4.57% | Health technology | Neutral |
 BMRNBioMarin Pharmaceutical Inc. | 11.09 B USD | 57.77 USD | +1.80% | 1.46 M | 0.87 | 17.11 | 3.38 USD | +154.90% | 0.00% | Health technology | Buy |
 BBIOBridgeBio Pharma, Inc. | 10.2 B USD | 53.38 USD | +2.99% | 2.92 M | 1.22 | — | −4.09 USD | −55.29% | 0.00% | Health technology | Strong buy |
 EXELExelixis, Inc. | 10.2 B USD | 37.88 USD | +1.34% | 2.52 M | 1.03 | 18.17 | 2.09 USD | +78.54% | 0.00% | Health technology | Buy |
 MRNAModerna, Inc. | 9.78 B USD | 25.14 USD | +3.54% | 13.04 M | 1.17 | — | −7.52 USD | +51.13% | 0.00% | Health technology | Neutral |
 IONSIonis Pharmaceuticals, Inc. | 9.76 B USD | 61.23 USD | +3.17% | 3.2 M | 0.75 | — | −1.85 USD | +26.70% | 0.00% | Health technology | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 9.65 B USD | 432.89 USD | +0.39% | 281.2 K | 0.74 | — | −12.85 USD | +49.62% | 0.00% | Health technology | Strong buy |
 VRNAVerona Pharma plc Sponsored ADRDR | 9.14 B USD | 106.31 USD | +0.07% | 2.48 M | 1.81 | — | −1.03 USD | +33.76% | 0.00% | Health technology | Neutral |
 ROIVRoivant Sciences Ltd. | 8.82 B USD | 12.92 USD | +2.78% | 8.6 M | 1.46 | — | −0.70 USD | −112.54% | 0.00% | Health technology | Strong buy |
 HALOHalozyme Therapeutics, Inc. | 8.76 B USD | 74.93 USD | +2.08% | 1.89 M | 0.87 | 17.12 | 4.38 USD | +69.71% | 0.00% | Health technology | Buy |
 GRFSGrifols, S.A. Sponsored ADR Class BDR | 8.63 B USD | 10.13 USD | +2.32% | 424 K | 0.80 | 21.13 | 0.48 USD | +98.22% | 1.41% | Health technology | Neutral |
 JAZZJazz Pharmaceuticals plc | 7.86 B USD | 129.50 USD | +1.16% | 718.36 K | 0.93 | — | −6.75 USD | −220.52% | 0.00% | Health technology | Strong buy |
 RVMDRevolution Medicines, Inc. | 7.57 B USD | 40.50 USD | +3.98% | 1.71 M | 0.88 | — | −4.50 USD | −23.49% | 0.00% | Health technology | Strong buy |
 GHGuardant Health, Inc. | 7.5 B USD | 60.13 USD | −2.00% | 2.89 M | 1.27 | — | −3.35 USD | +18.25% | 0.00% | Health services | Buy |
 RYTMRhythm Pharmaceuticals, Inc. | 6.78 B USD | 102.12 USD | −2.34% | 533.59 K | 0.91 | — | −3.02 USD | +30.87% | 0.00% | Health technology | Strong buy |
 LEGNLegend Biotech Corp. Sponsored ADRDR | 6.66 B USD | 36.08 USD | +3.12% | 1.46 M | 1.58 | — | −1.77 USD | −13.20% | 0.00% | Health technology | Strong buy |
 RNAAvidity Biosciences, Inc. | 6.48 B USD | 50.36 USD | +3.90% | 7.39 M | 3.72 | — | −3.56 USD | −20.45% | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 6.34 B USD | 53.01 USD | +6.55% | 3.72 M | 1.09 | — | −5.12 USD | +4.66% | 0.00% | Health technology | Strong buy |
 AXSMAxsome Therapeutics, Inc. | 6.25 B USD | 125.17 USD | +0.61% | 506.67 K | 0.88 | — | −5.07 USD | +22.16% | 0.00% | Health technology | Strong buy |
 NUVLNuvalent, Inc. | 5.83 B USD | 80.89 USD | +1.53% | 438.32 K | 0.99 | — | −4.90 USD | −76.16% | 0.00% | Health technology | Strong buy |
 MRUSMerus N.V. | 5.1 B USD | 67.47 USD | +1.87% | 635.51 K | 1.06 | — | −5.54 USD | −92.92% | 0.00% | Health technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 4.99 B USD | 54.86 USD | +4.02% | 2.74 M | 1.78 | — | −5.42 USD | −68.01% | 0.00% | Health technology | Buy |
 ALKSAlkermes plc | 4.94 B USD | 29.94 USD | +3.53% | 2.5 M | 1.68 | 14.37 | 2.08 USD | +23.42% | 0.00% | Health technology | Buy |
 PTCTPTC Therapeutics, Inc. | 4.55 B USD | 57.26 USD | −1.29% | 1.52 M | 1.36 | 8.21 | 6.97 USD | — | 0.00% | Health technology | Buy |
 KRYSKrystal Biotech, Inc. | 4.35 B USD | 150.27 USD | +0.35% | 324.26 K | 1.27 | 30.57 | 4.92 USD | +34.55% | 0.00% | Health technology | Strong buy |
 PCVXVaxcyte, Inc. | 4.29 B USD | 33.02 USD | +2.71% | 1.38 M | 0.90 | — | −4.19 USD | +11.84% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 4.26 B USD | 25.26 USD | −0.94% | 1.11 M | 0.55 | 18.98 | 1.33 USD | +645.55% | 0.00% | Health technology | Buy |
 ACLXArcellx, Inc. | 4.03 B USD | 72.62 USD | +0.64% | 364.16 K | 0.63 | — | −3.41 USD | −216.87% | 0.00% | Health technology | Strong buy |
 ADMAADMA Biologics Inc | 4.03 B USD | 16.87 USD | −0.21% | 2.79 M | 0.90 | 19.86 | 0.85 USD | +504.05% | 0.00% | Health technology | Buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 4.02 B USD | 29.08 USD | +3.84% | 2.72 M | 0.87 | — | −1.26 USD | +72.84% | 0.00% | Health technology | Buy |
 MIRMMirum Pharmaceuticals, Inc. | 3.82 B USD | 76.06 USD | +2.53% | 445.65 K | 0.48 | — | −1.21 USD | +48.34% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 3.77 B USD | 60.53 USD | +1.56% | 1.93 M | 2.29 | 84.94 | 0.71 USD | −72.87% | 0.00% | Health technology | Strong buy |
 AKROAkero Therapeutics, Inc. | 3.58 B USD | 44.72 USD | +1.57% | 2.34 M | 3.24 | — | −3.80 USD | −11.39% | 0.00% | Health technology | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 3.55 B USD | 28.13 USD | −1.82% | 2.81 M | 1.55 | — | −1.82 USD | +33.45% | 0.00% | Health technology | Buy |
 ZLABZai Lab Ltd. Sponsored ADRDR | 3.46 B USD | 30.76 USD | +2.53% | 925.96 K | 1.63 | — | −2.05 USD | +33.33% | 0.00% | Health technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 3.35 B USD | 35.61 USD | +3.97% | 1.42 M | 1.23 | — | −4.11 USD | −9.10% | 0.00% | Health technology | Strong buy |
 LGNDLigand Pharmaceuticals Incorporated | 3.27 B USD | 166.75 USD | −0.59% | 193.97 K | 1.34 | — | −4.00 USD | −272.89% | 0.00% | Health technology | Strong buy |
 INDVIndivior PLC | 3.12 B USD | 24.98 USD | +1.01% | 3.44 M | 1.78 | 35.24 | 0.71 USD | — | 0.00% | Health technology | Strong buy |
 KYMRKymera Therapeutics, Inc. | 3.11 B USD | 43.51 USD | +3.10% | 575.31 K | 0.88 | — | −3.48 USD | −44.09% | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.07 B USD | 31.82 USD | +1.73% | 1.33 M | 1.00 | — | −5.53 USD | +24.18% | 0.00% | Health technology | Strong buy |
 NAMSNewAmsterdam Pharma Company N.V. | 3.04 B USD | 27.00 USD | +5.22% | 1.57 M | 2.01 | — | −1.61 USD | −1,096.60% | 0.00% | Health technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 3.02 B USD | 39.21 USD | +1.48% | 646.09 K | 0.98 | — | −3.54 USD | −29.45% | 0.00% | Health technology | Strong buy |
 AMRXAmneal Pharmaceuticals, Inc. | 3.02 B USD | 9.62 USD | +0.73% | 1.27 M | 0.89 | 1,503.12 | 0.01 USD | — | 0.00% | Health technology | Strong buy |
 SRRKScholar Rock Holding Corporation | 3.02 B USD | 31.41 USD | −3.18% | 2.11 M | 1.23 | — | −3.02 USD | −29.50% | 0.00% | Health technology | Strong buy |
 IMVTImmunovant, Inc. | 2.99 B USD | 17.14 USD | +6.33% | 2.07 M | 1.37 | — | −2.85 USD | −48.38% | 0.00% | Health technology | Buy |
 HCMHUTCHMED (China) Limited Sponsored ADRDR | 2.8 B USD | 15.97 USD | +7.61% | 68.83 K | 1.11 | 5.96 | 2.68 USD | — | 0.00% | Health technology | Strong buy |
 MLYSMineralys Therapeutics, Inc. | 2.65 B USD | 34.80 USD | +5.07% | 3.74 M | 1.07 | — | −3.57 USD | −32.33% | 0.00% | Health technology | Strong buy |
 KNSAKiniksa Pharmaceuticals, Ltd. | 2.65 B USD | 35.71 USD | +0.56% | 328.3 K | 0.80 | 868.86 | 0.04 USD | — | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 2.58 B USD | 46.00 USD | +1.25% | 657.58 K | 1.02 | 40.20 | 1.14 USD | +1,195.81% | 0.00% | Health technology | Buy |
 VCYTVeracyte, Inc. | 2.55 B USD | 32.43 USD | +2.89% | 1.57 M | 1.69 | 97.48 | 0.33 USD | — | 0.00% | Health technology | Buy |
 CGONCG Oncology, Inc. | 2.52 B USD | 33.07 USD | +6.88% | 2.02 M | 3.29 | — | −1.68 USD | — | 0.00% | Health technology | Strong buy |
 ALVOAlvotech | 2.51 B USD | 8.33 USD | +3.61% | 448.25 K | 1.21 | 39.69 | 0.21 USD | — | 0.00% | Health technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 2.46 B USD | 7.99 USD | −0.37% | 5.56 M | 1.44 | — | −0.12 USD | +69.35% | 0.00% | Health technology | Strong buy |
 TARSTarsus Pharmaceuticals, Inc. | 2.43 B USD | 57.63 USD | +0.35% | 683.54 K | 1.20 | — | −2.33 USD | +48.06% | 0.00% | Health technology | Strong buy |
 IDYAIDEAYA Biosciences, Inc. | 2.38 B USD | 27.16 USD | +5.15% | 1.65 M | 1.65 | — | −3.79 USD | −73.55% | 0.00% | Health technology | Strong buy |
 OCULOcular Therapeutix, Inc. | 2.37 B USD | 13.60 USD | +7.09% | 4.98 M | 2.34 | — | −1.28 USD | +5.68% | 0.00% | Health technology | Strong buy |
 IBRXImmunityBio, Inc. | 2.27 B USD | 2.40 USD | +0.42% | 5.89 M | 0.79 | — | −0.49 USD | +47.26% | 0.00% | Health technology | Strong buy |
 APGEApogee Therapeutics, Inc. | 2.26 B USD | 37.87 USD | +1.99% | 498.29 K | 1.24 | — | −4.08 USD | −79.09% | 0.00% | Health technology | Strong buy |
 DNLIDenali Therapeutics Inc. | 2.26 B USD | 15.43 USD | +4.33% | 4.19 M | 1.89 | — | −2.81 USD | +1.62% | 0.00% | Health technology | Strong buy |
 GLPGGalapagos NV Sponsored ADRDR | 2.18 B USD | 33.36 USD | +4.54% | 316.62 K | 1.58 | — | −4.70 USD | −94.37% | 0.00% | Health technology | Neutral |
 IRONDisc Medicine, Inc. | 2.11 B USD | 60.76 USD | +0.95% | 196.28 K | 0.80 | — | −4.48 USD | −22.19% | 0.00% | Health technology | Strong buy |
 BEAMBeam Therapeutics Inc. | 2.11 B USD | 20.88 USD | +12.62% | 4.72 M | 1.73 | — | −4.51 USD | −150.05% | 0.00% | Health technology | Strong buy |
 CNTACentessa Pharmaceuticals PLC ADRDR | 2.11 B USD | 15.73 USD | −0.38% | 952.27 K | 0.88 | — | −1.78 USD | −14.45% | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 2.09 B USD | 36.01 USD | −0.33% | 1.48 M | 1.69 | 3.26 | 11.05 USD | — | 0.00% | Health technology | Buy |
 HRMYHarmony Biosciences Holdings, Inc. | 2.07 B USD | 35.99 USD | −0.85% | 742.37 K | 1.27 | 11.60 | 3.10 USD | +58.86% | 0.00% | Health technology | Strong buy |
 ANIPANI Pharmaceuticals, Inc. | 2.07 B USD | 95.35 USD | −0.68% | 414.02 K | 0.95 | — | −0.77 USD | −162.85% | 0.00% | Health technology | Strong buy |
 ARQTArcutis Biotherapeutics, Inc. | 2.06 B USD | 17.15 USD | +5.80% | 2.69 M | 2.10 | — | −0.74 USD | +65.91% | 0.00% | Health technology | Strong buy |
 DYNDyne Therapeutics, Inc. | 2.02 B USD | 14.22 USD | +7.40% | 2.42 M | 0.93 | — | −3.86 USD | −7.71% | 0.00% | Health technology | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2 B USD | 4.61 USD | +1.99% | 13.76 M | 0.97 | — | −1.79 USD | −10.08% | 0.00% | Health technology | Neutral |
 ADPTAdaptive Biotechnologies Corporation | 1.96 B USD | 12.85 USD | −1.31% | 1.37 M | 0.77 | — | −0.81 USD | +44.48% | 0.00% | Health technology | Strong buy |
 TVTXTravere Therapeutics, Inc. | 1.93 B USD | 21.64 USD | +2.32% | 3.91 M | 1.94 | — | −2.04 USD | +57.84% | 0.00% | Health technology | Strong buy |
 IMCRImmunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 ShDR | 1.87 B USD | 37.20 USD | +5.50% | 638.44 K | 2.23 | — | −0.41 USD | +61.68% | 0.00% | Health technology | Buy |
 SRPTSarepta Therapeutics, Inc. | 1.83 B USD | 18.71 USD | +1.35% | 5.18 M | 0.51 | — | −0.76 USD | −287.54% | 0.00% | Health technology | Neutral |
 COGTCogent Biosciences, Inc. | 1.82 B USD | 13.05 USD | +0.85% | 1.85 M | 1.43 | — | −2.42 USD | +2.25% | 0.00% | Health technology | Strong buy |
 MESOMesoblast Limited Sponsored ADRDR | 1.77 B USD | 14.39 USD | +6.43% | 379.26 K | 1.71 | — | −0.85 USD | +4.89% | 0.00% | Health technology | Strong buy |
 TXG10x Genomics, Inc. | 1.74 B USD | 13.96 USD | +2.87% | 1.88 M | 0.90 | — | −0.70 USD | +65.24% | 0.00% | Health technology | Buy |
 BCRXBioCryst Pharmaceuticals, Inc. | 1.74 B USD | 8.27 USD | 0.00% | 3.09 M | 1.43 | — | −0.17 USD | +76.20% | 0.00% | Health technology | Strong buy |
 VCELVericel Corporation | 1.72 B USD | 34.05 USD | +1.13% | 653.08 K | 0.99 | 273.06 | 0.12 USD | +3,017.50% | 0.00% | Health technology | Strong buy |